Ramucirumab for Colon Cancer and the Problem of Rising Prices Independent of Benefits. Academic Article uri icon

Overview

abstract

  • The discussion of value has moved from the philosophical, in which “value” was held out as an amorphous “eye of the beholder” concept, to an operationalized construct that is now directly affecting prescribing decisions. This is appropriate, given the large differences in price that seem disassociated from value.

publication date

  • August 11, 2015

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Colonic Neoplasms

Identity

PubMed Central ID

  • PMC4571809

Scopus Document Identifier

  • 84940646699

Digital Object Identifier (DOI)

  • 10.1634/theoncologist.2015-0257

PubMed ID

  • 26265223

Additional Document Info

volume

  • 20

issue

  • 9